Table 3.
ER | PgR | HER2 | Ki67 | Stathmin | IGF1-1R | IRS-1 | |
---|---|---|---|---|---|---|---|
Pre-treatment | |||||||
PgR | −0.17 | 1 | |||||
HER2 | 0 | −0.27 | 1 | ||||
Ki67 | 0.18 | −0.17 | −0.07 | 1 | |||
Stathmin | 0.31* | −0.01 | 0.04 | 0.38* | 1 | ||
IGF1-1R | 0.28 | −0.06 | −0.08 | −0.17 | 0.02 | 1 | |
IRS-1 | 0.48* | −0.11 | −0.03 | 0.48* | 0.17 | 0.2 | 1 |
PTEN | −0.28 | 0.08 | −0.02 | −0.12 | −0.44* | 0.05 | −0.13 |
Post-treatment | |||||||
PgR | 0.21 | 1 | |||||
HER2 | 0.15 | −0.09 | 1 | ||||
Ki67 | −0.29* | 0.02 | −0.1 | 1 | |||
Stathmin | −0.01 | −0.06 | −0.33* | 0.41* | 1 | ||
IGF1-1R | 0.52* | 0.22 | −0.09 | −0.27 | 0 | 1 | |
IRS-1 | 0.52* | −0.02 | 0.17 | 0.08 | 0.18 | 0.22 | 1 |
PTEN | 0.16 | −0.04 | 0.1 | 0.13 | 0.28 | −0.14 | 0.45* |
*P ≤ 0.05.